Global Large Volume Parenteral (LVP) Market Insights and Forecast to 2027

Publisher Name :
Date: 11-Jun-2021
No. of pages: 148
Inquire Before Buying

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered.

Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body.

Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

The first main kind is Soft Bag LVP, it hold a comparatively larger share in global market, which accounts for about 61.37% in 2018.

Another main kind is Glass Bottle LVP, for many companies, Glass Bottle LVP is attractive because of the market consumption need in the future. The Glass Bottle LVP share the rest 22.34% market share in 2018.

Plastic Bottle LVP hold the rest share, which accounts for about 16.29% in 2018.From the view of region, Asia-Pacific have a larger market share in 2018 which account for 46.29%, and will witness a stable growth in following years. North America and Europe hold a market share of 25.63% and 23.99% will still play an important role which cannot be ignored. Any changes from North America and Europe might affect the development trend of Large Volume Parenteral (LVP). South America and Middle East & Africa also play important roles in global market, but it will witness the comparatively low market share within selected regions.

Market Analysis and Insights: Global Large Volume Parenteral (LVP) Market

The global Large Volume Parenteral (LVP) market is valued at US$ 10710 million in 2019. The market size will reach US$ 19440 million by the end of 2026, growing at a CAGR of 8.8% during 2021-2026.

Global Large Volume Parenteral (LVP) Scope and Market Size

Large Volume Parenteral (LVP) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Large Volume Parenteral (LVP) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

- Soft Bag LVP

- Plastic Bottle LVP

- Glass Bottle LVP

- In 2018, Soft Bag LVP accounted for a major share of 61% in the global Large Volume Parenteral (LVP) market. And this product segment is poised to reach 15402 M Units by 2024 from 13868 M Units in 2019.

Segment by Application

- Basic Infusion

- Therapeutic Infusion

- Nutritious Infusion

By Company

- Baxter Healthcare

- Kelun Pharma

- B. Braun

- Fresenius

- Teva Pharmaceutical Industries

- Pfizer (Hospira)

- Ostuka Pharmaceutical

- CR Double-Crane

- Pisa

- Huaren

- Patheon

- Aspen Holdings

- Beximco Pharma

- Cook Pharmica

- Albert David

- PSI Ltd

- Ozon Pharmaceuticals

- BAG Healthcare

- BML Parenteral Drugs

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

Global Large Volume Parenteral (LVP) Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Large Volume Parenteral (LVP) Product Introduction
1.2 Market by Type
1.2.1 Global Large Volume Parenteral (LVP) Market Size Growth Rate by Type
1.4.2 Soft Bag LVP
1.4.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Market by Application
1.3.1 Global Large Volume Parenteral (LVP) Market Size Growth Rate by Application
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Large Volume Parenteral (LVP) Sales Estimates and Forecasts 2016-2027
2.2 Global Large Volume Parenteral (LVP) Revenue Estimates and Forecasts 2016-2027
2.3 Global Large Volume Parenteral (LVP) Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Large Volume Parenteral (LVP) Regions by Sales
2.4.1 Global Top Large Volume Parenteral (LVP) Regions by Sales (2016-2021)
2.4.2 Global Top Large Volume Parenteral (LVP) Regions by Sales (2022-2027)
2.5 Global Top Large Volume Parenteral (LVP) Regions by Revenue
2.5.1 Global Top Large Volume Parenteral (LVP) Regions by Revenue (2016-2021)
2.5.2 Global Top Large Volume Parenteral (LVP) Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Large Volume Parenteral (LVP) Sales by Manufacturers
3.1.1 Global Top Large Volume Parenteral (LVP) Manufacturers by Sales (2016-2021)
3.1.2 Global Top Large Volume Parenteral (LVP) Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Large Volume Parenteral (LVP) Sales in 2020
3.2 Global Large Volume Parenteral (LVP) Revenue by Manufacturers
3.2.1 Global Top Large Volume Parenteral (LVP) Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Large Volume Parenteral (LVP) Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Large Volume Parenteral (LVP) Revenue in 2020
3.3 Global Large Volume Parenteral (LVP) Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Large Volume Parenteral (LVP) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Large Volume Parenteral (LVP) Sales by Type
4.1.1 Global Large Volume Parenteral (LVP) Historical Sales by Type (2016-2021)
4.1.2 Global Large Volume Parenteral (LVP) Forecasted Sales by Type (2022-2027)
4.1.3 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2027)
4.2 Global Large Volume Parenteral (LVP) Revenue by Type
4.2.1 Global Large Volume Parenteral (LVP) Historical Revenue by Type (2016-2021)
4.2.2 Global Large Volume Parenteral (LVP) Forecasted Revenue by Type (2022-2027)
4.2.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2016-2027)
4.3 Global Large Volume Parenteral (LVP) Price by Type
4.3.1 Global Large Volume Parenteral (LVP) Price by Type (2016-2021)
4.3.2 Global Large Volume Parenteral (LVP) Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Large Volume Parenteral (LVP) Sales by Application
5.1.1 Global Large Volume Parenteral (LVP) Historical Sales by Application (2016-2021)
5.1.2 Global Large Volume Parenteral (LVP) Forecasted Sales by Application (2022-2027)
5.1.3 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2027)
5.2 Global Large Volume Parenteral (LVP) Revenue by Application
5.2.1 Global Large Volume Parenteral (LVP) Historical Revenue by Application (2016-2021)
5.2.2 Global Large Volume Parenteral (LVP) Forecasted Revenue by Application (2022-2027)
5.2.3 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2016-2027)
5.3 Global Large Volume Parenteral (LVP) Price by Application
5.3.1 Global Large Volume Parenteral (LVP) Price by Application (2016-2021)
5.3.2 Global Large Volume Parenteral (LVP) Price Forecast by Application (2022-2027)
6 North America
6.1 North America Large Volume Parenteral (LVP) Market Size by Type
6.1.1 North America Large Volume Parenteral (LVP) Sales by Type (2016-2027)
6.1.2 North America Large Volume Parenteral (LVP) Revenue by Type (2016-2027)
6.2 North America Large Volume Parenteral (LVP) Market Size by Application
6.2.1 North America Large Volume Parenteral (LVP) Sales by Application (2016-2027)
6.2.2 North America Large Volume Parenteral (LVP) Revenue by Application (2016-2027)
6.3 North America Large Volume Parenteral (LVP) Market Size by Country
6.3.1 North America Large Volume Parenteral (LVP) Sales by Country (2016-2027)
6.3.2 North America Large Volume Parenteral (LVP) Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Large Volume Parenteral (LVP) Market Size by Type
7.1.1 Europe Large Volume Parenteral (LVP) Sales by Type (2017-2027)
7.1.2 Europe Large Volume Parenteral (LVP) Revenue by Type (2017-2027)
7.2 Europe Large Volume Parenteral (LVP) Market Size by Application
7.2.1 Europe Large Volume Parenteral (LVP) Sales by Application (2017-2027)
7.2.2 Europe Large Volume Parenteral (LVP) Revenue by Application (2017-2027)
7.3 Europe Large Volume Parenteral (LVP) Market Size by Country
7.3.1 Europe Large Volume Parenteral (LVP) Sales by Country (2017-2027)
7.3.2 Europe Large Volume Parenteral (LVP) Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Large Volume Parenteral (LVP) Market Size by Type
8.1.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Type (2018-2027)
8.1.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Type (2018-2027)
8.2 Asia Pacific Large Volume Parenteral (LVP) Market Size by Application
8.2.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Application (2018-2027)
8.2.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Application (2018-2027)
8.3 Asia Pacific Large Volume Parenteral (LVP) Market Size by Region
8.3.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2018-2027)
8.3.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Large Volume Parenteral (LVP) Market Size by Type
9.1.1 Latin America Large Volume Parenteral (LVP) Sales by Type (2019-2027)
9.1.2 Latin America Large Volume Parenteral (LVP) Revenue by Type (2019-2027)
9.2 Latin America Large Volume Parenteral (LVP) Market Size by Application
9.2.1 Latin America Large Volume Parenteral (LVP) Sales by Application (2019-2027)
9.2.2 Latin America Large Volume Parenteral (LVP) Revenue by Application (2019-2027)
9.3 Latin America Large Volume Parenteral (LVP) Market Size by Country
9.3.1 Latin America Large Volume Parenteral (LVP) Sales by Country (2019-2027)
9.3.2 Latin America Large Volume Parenteral (LVP) Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Type
6.1.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Type (2016-2027)
6.1.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Type (2016-2027)
6.2 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Application
6.2.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Application (2016-2027)
6.2.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Application (2016-2027)
6.3 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Country
6.3.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2016-2027)
6.3.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Baxter Healthcare
11.1.1 Baxter Healthcare Corporation Information
11.1.2 Baxter Healthcare Overview
11.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Description
11.1.5 Baxter Healthcare Related Developments
11.2 Kelun Pharma
11.2.1 Kelun Pharma Corporation Information
11.2.2 Kelun Pharma Overview
11.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Description
11.2.5 Kelun Pharma Related Developments
11.3 B. Braun
11.3.1 B. Braun Corporation Information
11.3.2 B. Braun Overview
11.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 B. Braun Large Volume Parenteral (LVP) Product Description
11.3.5 B. Braun Related Developments
11.4 Fresenius
11.4.1 Fresenius Corporation Information
11.4.2 Fresenius Overview
11.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Fresenius Large Volume Parenteral (LVP) Product Description
11.4.5 Fresenius Related Developments
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Corporation Information
11.5.2 Teva Pharmaceutical Industries Overview
11.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Description
11.5.5 Teva Pharmaceutical Industries Related Developments
11.6 Pfizer (Hospira)
11.6.1 Pfizer (Hospira) Corporation Information
11.6.2 Pfizer (Hospira) Overview
11.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Description
11.6.5 Pfizer (Hospira) Related Developments
11.7 Ostuka Pharmaceutical
11.7.1 Ostuka Pharmaceutical Corporation Information
11.7.2 Ostuka Pharmaceutical Overview
11.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Description
11.7.5 Ostuka Pharmaceutical Related Developments
11.8 CR Double-Crane
11.8.1 CR Double-Crane Corporation Information
11.8.2 CR Double-Crane Overview
11.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Description
11.8.5 CR Double-Crane Related Developments
11.9 Pisa
11.9.1 Pisa Corporation Information
11.9.2 Pisa Overview
11.9.3 Pisa Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Pisa Large Volume Parenteral (LVP) Product Description
11.9.5 Pisa Related Developments
11.10 Huaren
11.10.1 Huaren Corporation Information
11.10.2 Huaren Overview
11.10.3 Huaren Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Huaren Large Volume Parenteral (LVP) Product Description
11.10.5 Huaren Related Developments
11.1 Baxter Healthcare
11.1.1 Baxter Healthcare Corporation Information
11.1.2 Baxter Healthcare Overview
11.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Description
11.1.5 Baxter Healthcare Related Developments
11.12 Aspen Holdings
11.12.1 Aspen Holdings Corporation Information
11.12.2 Aspen Holdings Overview
11.12.3 Aspen Holdings Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Aspen Holdings Product Description
11.12.5 Aspen Holdings Related Developments
11.13 Beximco Pharma
11.13.1 Beximco Pharma Corporation Information
11.13.2 Beximco Pharma Overview
11.13.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Beximco Pharma Product Description
11.13.5 Beximco Pharma Related Developments
11.14 Cook Pharmica
11.14.1 Cook Pharmica Corporation Information
11.14.2 Cook Pharmica Overview
11.14.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Cook Pharmica Product Description
11.14.5 Cook Pharmica Related Developments
11.15 Albert David
11.15.1 Albert David Corporation Information
11.15.2 Albert David Overview
11.15.3 Albert David Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Albert David Product Description
11.15.5 Albert David Related Developments
11.16 PSI Ltd
11.16.1 PSI Ltd Corporation Information
11.16.2 PSI Ltd Overview
11.16.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 PSI Ltd Product Description
11.16.5 PSI Ltd Related Developments
11.17 Ozon Pharmaceuticals
11.17.1 Ozon Pharmaceuticals Corporation Information
11.17.2 Ozon Pharmaceuticals Overview
11.17.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 Ozon Pharmaceuticals Product Description
11.17.5 Ozon Pharmaceuticals Related Developments
11.18 BAG Healthcare
11.18.1 BAG Healthcare Corporation Information
11.18.2 BAG Healthcare Overview
11.18.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.18.4 BAG Healthcare Product Description
11.18.5 BAG Healthcare Related Developments
11.19 BML Parenteral Drugs
11.19.1 BML Parenteral Drugs Corporation Information
11.19.2 BML Parenteral Drugs Overview
11.19.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Price, Revenue and Gross Margin (2016-2021)
11.19.4 BML Parenteral Drugs Product Description
11.19.5 BML Parenteral Drugs Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Large Volume Parenteral (LVP) Value Chain Analysis
12.2 Large Volume Parenteral (LVP) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Large Volume Parenteral (LVP) Production Mode & Process
12.4 Large Volume Parenteral (LVP) Sales and Marketing
12.4.1 Large Volume Parenteral (LVP) Sales Channels
12.4.2 Large Volume Parenteral (LVP) Distributors
12.5 Large Volume Parenteral (LVP) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Large Volume Parenteral (LVP) Industry Trends
13.2 Large Volume Parenteral (LVP) Market Drivers
13.3 Large Volume Parenteral (LVP) Market Challenges
13.4 Large Volume Parenteral (LVP) Market Restraints
14 Key Findings in The Global Large Volume Parenteral (LVP) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Large Volume Parenteral (LVP) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Soft Bag LVP
Table 3. Major Manufacturers of Plastic Bottle LVP
Table 4. Major Manufacturers of Glass Bottle LVP
Table 5. Global Large Volume Parenteral (LVP) Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Large Volume Parenteral (LVP) Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Large Volume Parenteral (LVP) Sales by Region (2016-2021) & (M Units)
Table 8. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
Table 9. Global Large Volume Parenteral (LVP) Sales by Region (2016-2021) & (M Units)
Table 10. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2022-2027)
Table 11. Global Large Volume Parenteral (LVP) Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2016-2021)
Table 13. Global Large Volume Parenteral (LVP) Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2022-2027)
Table 15. Global Large Volume Parenteral (LVP) Sales by Manufacturers (2016-2021) & (M Units)
Table 16. Global Large Volume Parenteral (LVP) Sales Share by Manufacturers (2016-2021)
Table 17. Global Large Volume Parenteral (LVP) Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2016-2021)
Table 19. Large Volume Parenteral (LVP) Price by Manufacturers 2016-2021 (USD/Unit)
Table 20. Global Large Volume Parenteral (LVP) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Large Volume Parenteral (LVP) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Large Volume Parenteral (LVP) as of 2020)
Table 22. Large Volume Parenteral (LVP) Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Large Volume Parenteral (LVP) Product Offered
Table 24. Date of Manufacturers Enter into Large Volume Parenteral (LVP) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 27. Global Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 28. Global Large Volume Parenteral (LVP) Sales Share by Type (2016-2021)
Table 29. Global Large Volume Parenteral (LVP) Sales Share by Type (2022-2027)
Table 30. Global Large Volume Parenteral (LVP) Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Large Volume Parenteral (LVP) Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Large Volume Parenteral (LVP) Revenue Share by Type (2016-2021)
Table 33. Global Large Volume Parenteral (LVP) Revenue Share by Type (2022-2027)
Table 34. Large Volume Parenteral (LVP) Price by Type (2016-2021) & (USD/Unit)
Table 35. Global Large Volume Parenteral (LVP) Price Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 37. Global Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 38. Global Large Volume Parenteral (LVP) Sales Share by Application (2016-2021)
Table 39. Global Large Volume Parenteral (LVP) Sales Share by Application (2022-2027)
Table 40. Global Large Volume Parenteral (LVP) Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Large Volume Parenteral (LVP) Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Large Volume Parenteral (LVP) Revenue Share by Application (2016-2021)
Table 43. Global Large Volume Parenteral (LVP) Revenue Share by Application (2022-2027)
Table 44. Large Volume Parenteral (LVP) Price by Application (2016-2021) & (USD/Unit)
Table 45. Global Large Volume Parenteral (LVP) Price Forecast by Application (2022-2027) & (USD/Unit)
Table 46. North America Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 47. North America Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 48. North America Large Volume Parenteral (LVP) Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Large Volume Parenteral (LVP) Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 51. North America Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 52. North America Large Volume Parenteral (LVP) Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Large Volume Parenteral (LVP) Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Large Volume Parenteral (LVP) Sales by Country (2016-2021) & (M Units)
Table 55. North America Large Volume Parenteral (LVP) Sales by Country (2022-2027) & (M Units)
Table 56. North America Large Volume Parenteral (LVP) Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Large Volume Parenteral (LVP) Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 59. Europe Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 60. Europe Large Volume Parenteral (LVP) Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Large Volume Parenteral (LVP) Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 63. Europe Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 64. Europe Large Volume Parenteral (LVP) Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Large Volume Parenteral (LVP) Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Large Volume Parenteral (LVP) Sales by Country (2016-2021) & (M Units)
Table 67. Europe Large Volume Parenteral (LVP) Sales by Country (2022-2027) & (M Units)
Table 68. Europe Large Volume Parenteral (LVP) Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Large Volume Parenteral (LVP) Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 71. Asia Pacific Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 72. Asia Pacific Large Volume Parenteral (LVP) Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Large Volume Parenteral (LVP) Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 75. Asia Pacific Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 76. Asia Pacific Large Volume Parenteral (LVP) Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Large Volume Parenteral (LVP) Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2016-2021) & (M Units)
Table 79. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2022-2027) & (M Units)
Table 80. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 83. Latin America Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 84. Latin America Large Volume Parenteral (LVP) Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Large Volume Parenteral (LVP) Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 87. Latin America Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 88. Latin America Large Volume Parenteral (LVP) Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Large Volume Parenteral (LVP) Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Large Volume Parenteral (LVP) Sales by Country (2016-2021) & (M Units)
Table 91. Latin America Large Volume Parenteral (LVP) Sales by Country (2022-2027) & (M Units)
Table 92. Latin America Large Volume Parenteral (LVP) Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Large Volume Parenteral (LVP) Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Large Volume Parenteral (LVP) Sales by Type (2016-2021) & (M Units)
Table 95. Middle East and Africa Large Volume Parenteral (LVP) Sales by Type (2022-2027) & (M Units)
Table 96. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Large Volume Parenteral (LVP) Sales by Application (2016-2021) & (M Units)
Table 99. Middle East and Africa Large Volume Parenteral (LVP) Sales by Application (2022-2027) & (M Units)
Table 100. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2016-2021) & (M Units)
Table 103. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2022-2027) & (M Units)
Table 104. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2022-2027) & (US$ Million)
Table 106. Baxter Healthcare Corporation Information
Table 107. Baxter Healthcare Description and Major Businesses
Table 108. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 109. Baxter Healthcare Large Volume Parenteral (LVP) Product
Table 110. Baxter Healthcare Recent Developments
Table 111. Kelun Pharma Corporation Information
Table 112. Kelun Pharma Description and Major Businesses
Table 113. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 114. Kelun Pharma Large Volume Parenteral (LVP) Product
Table 115. Kelun Pharma Recent Developments
Table 116. B. Braun Corporation Information
Table 117. B. Braun Description and Major Businesses
Table 118. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 119. B. Braun Large Volume Parenteral (LVP) Product
Table 120. B. Braun Recent Developments
Table 121. Fresenius Corporation Information
Table 122. Fresenius Description and Major Businesses
Table 123. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 124. Fresenius Large Volume Parenteral (LVP) Product
Table 125. Fresenius Recent Developments
Table 126. Teva Pharmaceutical Industries Corporation Information
Table 127. Teva Pharmaceutical Industries Description and Major Businesses
Table 128. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 129. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product
Table 130. Teva Pharmaceutical Industries Recent Developments
Table 131. Pfizer (Hospira) Corporation Information
Table 132. Pfizer (Hospira) Description and Major Businesses
Table 133. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 134. Pfizer (Hospira) Large Volume Parenteral (LVP) Product
Table 135. Pfizer (Hospira) Recent Developments
Table 136. Ostuka Pharmaceutical Corporation Information
Table 137. Ostuka Pharmaceutical Description and Major Businesses
Table 138. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 139. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product
Table 140. Ostuka Pharmaceutical Recent Developments
Table 141. CR Double-Crane Corporation Information
Table 142. CR Double-Crane Description and Major Businesses
Table 143. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 144. CR Double-Crane Large Volume Parenteral (LVP) Product
Table 145. CR Double-Crane Recent Developments
Table 146. Pisa Corporation Information
Table 147. Pisa Description and Major Businesses
Table 148. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 149. Pisa Large Volume Parenteral (LVP) Product
Table 150. Pisa Recent Developments
Table 151. Huaren Corporation Information
Table 152. Huaren Description and Major Businesses
Table 153. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 154. Huaren Large Volume Parenteral (LVP) Product
Table 155. Huaren Recent Developments
Table 156. Patheon Corporation Information
Table 157. Patheon Description and Major Businesses
Table 158. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 159. Patheon Large Volume Parenteral (LVP) Product
Table 160. Patheon Recent Developments
Table 161. Aspen Holdings Corporation Information
Table 162. Aspen Holdings Description and Major Businesses
Table 163. Aspen Holdings Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 164. Aspen Holdings Large Volume Parenteral (LVP) Product
Table 165. Aspen Holdings Recent Developments
Table 166. Beximco Pharma Corporation Information
Table 167. Beximco Pharma Description and Major Businesses
Table 168. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 169. Beximco Pharma Large Volume Parenteral (LVP) Product
Table 170. Beximco Pharma Recent Developments
Table 171. Cook Pharmica Corporation Information
Table 172. Cook Pharmica Description and Major Businesses
Table 173. Cook Pharmica Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 174. Cook Pharmica Large Volume Parenteral (LVP) Product
Table 175. Cook Pharmica Recent Developments
Table 176. Albert David Corporation Information
Table 177. Albert David Description and Major Businesses
Table
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs